---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-065850"
form_type: "8-K"
ticker: "PHGE"
cik: "0001739174"
company_name: "BiomX Inc."
filed_at: "2026-06-05T20:30:42+00:00"
generated_at: "2026-06-05T20:40:46.613500+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# BiomX issues 1,013,637 shares on partial conversion of Mandragola note; grants 2M-share warrant

## Summary
- Issued 1,013,637 restricted shares upon partial conversion of $379K principal under 12% convertible note with Mandragola.
- Line of credit agreement dated May 13, 2026 provides up to $2M revolving credit at 12% annual interest.
- Issued five-year warrant to Mandragola to purchase 2M shares at $12.00 per share, subject to stockholder approval.
- Company now has 11,160,153 shares of common stock outstanding after conversion.
- Shares and warrant issued in reliance on Section 4(a)(2) exemption; no general solicitation.

## SEC filing metadata
- accession: 0001213900-26-065850
- form_type: 8-K
- ticker: PHGE
- cik: 0001739174
- company_name: BiomX Inc.
- filed_at: 2026-06-05T20:30:42+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739174/000121390026065850/0001213900-26-065850-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739174/000121390026065850/ea0293750-8k_biomx.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-065850
- JSON: https://secwatch.observer/filing/0001213900-26-065850.json
- Plain text: https://secwatch.observer/filing/0001213900-26-065850.txt

## Key facts
- Equity Issuances
  BiomX Inc. issued 1,013,637 restricted shares of common stock of common stock to three individual assignees upon partial conversion of a convertible promissory note originally issued to Mandragola Ltd. for conversion of approximately $379,000 in principal amount.
  - Security: common stock
  - Shares: 1,013,637 restricted shares of common stock
  - Purchaser: three individual assignees upon partial conversion of a convertible promissory note originally issued to Mandragola Ltd.
  - Consideration: conversion of approximately $379,000 in principal amount
  source text: NYSE American. The warrant was issued to Mandragola in reliance on Section 4(a)(2) of the Securities Act. The Conversion Shares were issued upon the conversion of approximately $379,000 in principal amount extended by Mandragola. The Conversion Shares have not been registered under the Securities Act of 1933 (as amended, the “Securities Act”) or under any state
  evidence_url: https://www.sec.gov/Archives/edgar/data/1739174/000121390026065850/0001213900-26-065850-index.htm
- Equity Issuances
  BiomX Inc. issued up to 2,000,000 shares of Common Stock of warrant to Mandragola Ltd. for additional consideration for making the Credit Line available.
  - Security: warrant
  - Shares: up to 2,000,000 shares of Common Stock
  - Purchaser: Mandragola Ltd.
  - Consideration: additional consideration for making the Credit Line available
  source text: As additional consideration for making the Credit Line available, the Company also issued to Mandragola a five-year warrant to purchase up to 2,000,000 shares of Common Stock at an exercise price of $12.00 per share, with a cashless exercise feature.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1739174/000121390026065850/0001213900-26-065850-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.